Consultant gynaecological oncologist, Dr Esther Moss, said the test could not only detect cancer recurrence more quickly but also avoid the need for confirmatory invasive biopsies and was undergoing further validation before being used in everyday clinical practice.
Trending
- Tumour cells shape their environment to protect them from the immune system
- The TCL Subtypes That Warrant Upfront Allogeneic Transplant Consolidation
- Does Exercise Improve Cancer Survival?
- Closing Reflections on BCMA-Directed Therapy in Relapsed/Refractory Multiple Myeloma
- How I’ve Stopped Letting My Unhealed Parents Define My Worth
- IASO208 Receives FDA IND Clearance for Relapsed/Refractory B-Cell Lymphoma
- Novel Macrocyclic EGFR TKI Shows Responses in EGFR C797S–Positive NSCLC
- Could tracking genetics help stop myeloma before it starts? – Cancer Research UK
Wednesday, September 16
